Oxbridge Re (NASDAQ:OXBR) Raised to Hold at Zacks Research

Oxbridge Re (NASDAQ:OXBR) was upgraded by equities researchers at Zacks Research to a “hold” rating in a research note issued to investors on Wednesday,Zacks.com reports.

Several other research analysts have also issued reports on OXBR. Weiss Ratings lowered Oxbridge Re from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, June 3rd. Maxim Group dropped their target price on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a research report on Tuesday. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $3.00.

Oxbridge Re Trading Down 7.3%

OXBR stock opened at $0.95 on Wednesday. Oxbridge Re has a 1-year low of $0.66 and a 1-year high of $2.86. The company has a current ratio of 8.15, a quick ratio of 8.15 and a debt-to-equity ratio of 0.16. The business’s 50 day moving average is $0.91 and its 200-day moving average is $1.05. The firm has a market cap of $7.73 million, a P/E ratio of -3.82 and a beta of 2.02.

Oxbridge Re (NASDAQ:OXBR) last posted its earnings results on Saturday, February 14th. The insurance provider reported $0.02 EPS for the quarter. The business had revenue of $0.58 million during the quarter. Oxbridge Re had a negative return on equity of 33.33% and a negative net margin of 76.47%. Equities analysts anticipate that Oxbridge Re will post -0.04 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Oxbridge Re

Several institutional investors have recently bought and sold shares of the business. Virtu Financial LLC bought a new stake in shares of Oxbridge Re during the third quarter worth $32,000. International Assets Investment Management LLC bought a new position in shares of Oxbridge Re in the fourth quarter valued at about $39,000. J.W. Cole Advisors Inc. lifted its position in Oxbridge Re by 106.1% during the 4th quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock worth $90,000 after buying an additional 35,000 shares in the last quarter. Finally, Henrickson Nauta Wealth Advisors Inc. lifted its position in Oxbridge Re by 100.0% during the 4th quarter. Henrickson Nauta Wealth Advisors Inc. now owns 137,400 shares of the insurance provider’s stock worth $185,000 after buying an additional 68,700 shares in the last quarter. Institutional investors own 5.64% of the company’s stock.

Trending Headlines about Oxbridge Re

Here are the key news stories impacting Oxbridge Re this week:

• Positive Sentiment: Maxim Group reiterated a Buy rating on Oxbridge Re and kept a $3.00 price target, signaling upside versus recent trading levels. The firm’s updated estimates also suggest the company could return to profitability in some quarters, including $0.04 EPS for Q2 2026. MarketBeat OXBR analyst report
• Positive Sentiment: Oxbridge Re’s subsidiary SurancePlus reported that its tokenized reinsurance offerings delivered 29.3% and 43.4% annualized returns, beating original targets of 20% and 42%. That may support investor confidence in the company’s digital RWA/reinsurance strategy. SurancePlus exceeds return targets release
• Neutral Sentiment: Maxim Group’s broader forecast still shows a loss-making profile for Oxbridge Re over the next several periods, including estimated annual losses of $(0.04) in FY2026 and $(0.13) in FY2027. Those projections keep the turnaround story speculative. MarketBeat OXBR analyst report
• Negative Sentiment: Despite the bullish analyst target, the company’s recent estimates still call for multiple quarters of negative EPS, which may weigh on sentiment if investors focus on execution risk and the pace of earnings recovery. MarketBeat OXBR analyst report

About Oxbridge Re

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.